![]() |
市场调查报告书
商品编码
1394210
全球低聚半乳糖 (GOS) 市场评估:依形式、应用、最终用途、地区、机会、预测(2016-2030 年)Galacto-oligosaccharides Market Assessment, By Form, By Application, By End-use, By Region, Opportunities and Forecast, 2016-2030F |
全球低聚半乳糖 (GOS) 市场规模预计将从 2022 年的 50.94 千吨增至 2030 年的 78.18 千吨,在 2023-2030 年预测期间复合年增长率为 5.5%。 市场受到促进其成长和繁荣的几个关键驱动因素的影响。 主要驱动因素之一是人们对肠道健康重要性的认识不断提高。 消费者现在越来越意识到健康的肠道菌丛如何影响他们的整体健康,导致对 GOS 等益生元成分的高需求。
功能性食品和饮料的日益普及也导致消费者寻求除基本营养之外还能提供健康益处的产品,而 GOS 越来越多地用于这些功能性产品中。这是因为 此外,由于 GOS 与母乳寡糖 (HMO) 相似,因此在婴儿配方奶粉中使用 GOS 正在推动婴儿营养领域的需求。
此外,功能性饮料(包括益生菌和益生元饮料)的开发正在扩大 GOS 的使用。 这些饮料因其改善消化健康的潜力而越来越受欢迎。 总而言之,研究和临床研究正在推动 GOS 市场的发展,因为正在进行的关于 GOS 健康益处的研究和临床研究的积极结果正在推动该成分的声誉和需求不断增长,并发挥着重要作用。
随着人们对宠物健康和营养重要性的认识不断增强,低聚半乳糖 (GOS) 在宠物饲料中的使用越来越受到关注。 GOS专注于促进宠物消化系统的健康,并为您的宠物提供多种益处,包括支持宠物的肠道菌丛、帮助消化以及减少胃肠道疾病的发生率。 此外,GOS 已显示出增强宠物免疫系统、增强抗病能力和减轻宠物过敏反应的潜力,使其成为治疗常见宠物过敏的宝贵成分。我们已经确立了自己的地位。
例如,Nestle Purina PetCare Co.投资 1.82 亿美元扩建其位于美国维吉尼亚州威廉王县的宠物护理产品製造工厂。 扩大生产和对宠物饲料的强劲需求正在推动全球低聚半乳糖(GOS)的发展。
低聚半乳糖 (GOS) 在营养保健品产业中发挥着至关重要的作用,并因其潜在的健康益处而受到广泛吹捧,特别是在支持肠道健康方面。 人们对消化健康的兴趣日益浓厚,推动了营养保健品领域对 GOS 的庞大需求。 此外,营养保健品产业的兴起也伴随着功能性饮料的发展。 这包括一系列产品,例如益生菌和益生元饮料和食品,旨在透过改善肠道微生物平衡来改善整体健康。
例如,2023 年7 月,FHIRST Living Soda 进入饮料市场,推出了一款开创性的全天然无糖饮料,该饮料采用益生菌和益生元的独特混合物来支持肠道健康。我证明了这一点。 随着世界各地功能性食品的不断推出,对低聚半乳糖(GOS)的需求不断增加。
GOS 一直是研究的重点,重点是其缓解胃肠道疾病相关症状的潜力,包括肠躁症 (IBS) 和发炎性肠道疾病 (IBD) 等疾病。 GOS 促进有益肠道细菌的生长,有望有助于促进肠道健康并减少相关症状。 除了解决胃肠道疾病外,它还用于治疗腹泻。 因此,它是某些旨在缓解腹泻的药物(例如口服补液盐)中的特色成分,特别注重对婴儿和幼儿的有效性。
例如,2023 年第一季度,Johnson & Johnson公布了骄人业绩,美国销售额增长约 10%,总计 125.2 亿美元。 药品销售的激增预计将导致 GOS 需求的增加。
本报告研究分析了全球低聚半乳糖(GOS)市场,提供市场规模和预测、市场动态、主要参与者的现状和前景等。
Global galacto-oligosaccharides market size was recorded at 50.94 kilotons in 2022, which is expected to grow to 78.18 kilotons in 2030 with a CAGR of 5.5%, during the forecast period between 2023 and 2030. The galacto-oligosaccharides market is influenced by several key drivers that have contributed to its growth and prominence. One of the primary drivers is the increasing awareness of the importance of gut health. Consumers are now more conscious of how a healthy gut microbiome can impact overall well-being, which has led to a higher demand for prebiotic ingredients, like GOS.
The rising popularity of functional foods and beverages is another significant driver as consumers seek products that offer health benefits beyond basic nutrition, and GOS is often used in these functional items. Additionally, the use of GOS in infant formula due to its similarity to human milk oligosaccharides (HMOs) has propelled demand in the infant nutrition segment.
Moreover, the development of functional beverages, including probiotic and prebiotic drinks, has expanded the use of GOS. These beverages have gained popularity for their potential to enhance digestive health. Conclusively, Research and clinical studies have played a significant role in advancing the GOS market as ongoing research into the health benefits of GOS and positive results from clinical studies have contributed to the growing reputation and demand for this ingredient.
The utilization of Galacto-oligosaccharides (GOS) in pet feed is gaining prominence, driven by the growing recognition of the significance of pet health and nutrition. GOS offers a range of benefits for pets, with a primary focus on enhancing their digestive health, and supports the pet's gut microbiome, aids in digestion, and diminishing the occurrence of gastrointestinal issues. Moreover, GOS has demonstrated its potential in fortifying the immune system of pets, bolstering their resistance to diseases and serve to mitigate allergic reactions in pets, thus establishing itself as a valuable ingredient for the management of common pet allergies.
For instance, Nestle Purina PetCare Co. allocated an investment of USD 182 million to expand its manufacturing facility for pet care products in King William County, Virginia, the United States. Expansion of manufacturing and strong demand for pet feed to strengthen the Galacto-oligosaccharides globally.
Galacto-oligosaccharides play a pivotal role in the dietary supplements industry, where it is widely promoted for its potential health benefits, particularly in supporting gut health. The increasing focus on digestive well-being has driven significant demand for GOS within the dietary supplements sector. Moreover, the surge in the dietary supplements industry has been accompanied by the development of functional beverages. It includes a range of products like probiotic and prebiotic drinks and foods that aim to enhance overall health through improved gut microbiome balance.
For instance, during July 2023, FHIRST Living Soda entered the beverage market, marking the pioneering all-natural, sugar-free drink that uniquely blends probiotics and prebiotics to support gut health. The rise in launches of functional foods across the globe increases the demand for galacto-oligosaccharides.
GOS has been the subject of research focused on its potential to mitigate symptoms associated with gastrointestinal disorders, including conditions like irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). GOS fosters the proliferation of beneficial gut bacteria and has shown promise and helps in enhancing gut health and diminishing associated symptoms. In addition to addressing gastrointestinal disorders, it is used for managing diarrhea. Therefore, it is a featured ingredient in specific pharmaceutical products, such as oral rehydration solutions, designed to alleviate diarrhea, with a particular focus on its efficacy in infants and young children.
For instance, during Q1 of 2023, Johnson & Johnson reported impressive results in their sales experiencing a robust upswing of nearly 10 percent in the United States, reaching a total of USD 12.52 billion. The upsurge in sales of pharmaceuticals is expected to contribute to rising demand for GOS.
The galacto-oligosaccharides market experienced significant disruption due to the outbreak of COVID-19. Although the pandemic had a relatively milder impact on the food and beverage industry compared to other sectors, it severely affected the industry's global supply chain, constraining its growth potential. The shift in consumer behavior during this time had a detrimental effect on purchasing patterns, resulting in several challenges, including operational halts, hindrances to business expansion, and suspended activities. However, on the other hand, the lockdown heightened demand for GOS in few applications as the need for pet feed and prebiotic drinks increased during the pandemic.
A huge percentage of the population of people across the globe is lactose intolerant, which is a major restrain to the market. However, the development of plant-based GOS will witness a consumption increase within this population.
The ongoing research of GOS in pharmaceuticals along with growing awareness of gut health will improve the demand for galacto-oligosaccharides market globally.
Key players in the galacto-oligosaccharide market are actively involved in the creation of innovative products, primarily intended to function as dietary supplements. This strategic initiative is coordinated with the increasing worldwide need for nutritional supplements and the industry's adaptability to changing consumer preferences in this regard. It underscores a dedication in addressing the rising market requirements for health-oriented products, emphasizing a pivotal role of galacto-oligosaccharide in modern dietary solutions.
For instance, in August 2022, FrieslandCampina Ingredients created a specialized prebiotic with the aim of spurring innovation in the expanding market for gut health supplements. Featuring an exceptionally high galacto-oligosaccharide content of more than 90%, Biotis GOS-OP High Purity stands as the company's most refined prebiotic ingredient.
All segments will be provided for all regions and countries covered:
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.